Drug Type Small molecule drug |
Synonyms ARN-24161 |
Target |
Mechanism DRDs modulators(Dopamine receptors modulators), GSK-3β inhibitors(Glycogen synthase kinase-3 beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bipolar Disorder | Preclinical | IT | - | |
Bipolar Disorder | Preclinical | IT | - | |
Bipolar Disorder | Preclinical | GB | - |